Therapeutic Potential of Docetaxel plus Cisplatin Chemotherapy for Myasthenia Gravis Patients with Metastatic Thymoma

Author:

Qi Guoyan1,Liu Peng1,Dong Huimin1,Gu Shanshan1,Yang Hongxia1,Xue Yinping1

Affiliation:

1. Myasthenia Gravis Treatment Center of Hebei Province, First Hospital of Shijiazhuang

Publisher

Tohoku University Medical Press

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference39 articles.

1. Albany, C. & Sonpavde, G. (2015) Docetaxel for the treatment of bladder cancer. Expert Opin. Investig. Drugs, 24, 1657-1664.

2. Bear, H.D., Anderson, S., Brown, A., Smith, R., Mamounas, E.P., Fisher, B., Margolese, R., Theoret, H., Soran, A., Wickerham, D.L. & Wolmark, N.; National Surgical Adjuvant Breast and Bowel Project Protocol B-27 (2003) The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J. Clin. Oncol., 21, 4165-4174.

3. Betticher, D.C., Has Schmitz, S.F., Tötsch, M., Hansen, E., Joss, C., von Briel, C., Schmid, R.A., Pless, M., Habicht, J., Roth, A.D., Spiliopoulos, A., Stahel, R., Weder, W., Stupp, R. & Egli, F. (2003) Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J. Clin. Oncol., 21, 1752-1759.

4. Bott, M.J., Wang, H., Travis, W., Riely, G.J., Bains, M., Downey, R., Rusch, V. & Huang, J. (2011) Management and outcomes of relapse after treatment for thymoma and thymic carcinoma. Ann. Thorac. Surg., 92, 1984-1992.

5. Brain, E.G., Bachelot, T., Serin, D., Kirscher, S., Graic, Y., Eymard, J.C., Extra, J.M., Combe, M., Fourme, E., Noguès, C. & Rouëssé, J.; RAPP-01 Trial Investigators (2005) Life-threatening sepsis associated with adjuvant doxorubicin plus docetaxel for intermediate-risk breast cancer. JAMA, 293, 2367-2371.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3